腹壁疝修补术中长期性能比较:生物、合成与长效可吸收补片的人群生存动力学分析
本研究采用人群生存动力学方法,对开放腹壁疝修补术(VHR)中三种补片的长期复发数据建模验证与预测。长效可吸收补片的中位总体复发时间最长(166.4个月),合成补片次之(132.1个月),生物补片最短(80个月)。5年和10年复发率同样以长效可吸收补片最低。
要点
- 长效可吸收补片中位复发时间166.4个月,长于合成补片132.1个月和生物补片80个月。
- 5年复发率:生物补片约41%、合成补片27%、长效可吸收补片22%。
- 生物补片与合成补片修补后2年内每6个月、之后每年随访至15年。
核心结论
- 长效可吸收补片的中位复发时间最长且5年、10年复发率最低,长期性能可能优于合成补片和生物补片。
研究设计与样本
- 采用人群生存动力学的单相非线性回归分析,对三种补片类型的开放腹壁疝修补术复发数据进行建模、验证与预测。
主要发现
- 中位总体复发时间:长效可吸收补片166.4个月,合成补片132.1个月,生物补片80个月。
- 5年复发率:生物补片约41%,合成补片27%,长效可吸收补片22%。
- 10年复发率:生物补片65%,合成补片47%,长效可吸收补片39%。
- 生物补片组「风险」修补比例最高,为42%。
- 术后15年时,生物补片和合成补片组中未复发者98%至99%在此后保持完好。
关键数值与推荐
- 生物补片和合成补片修补后应每6个月评估复发持续2年,之后每年一次至15年。
- 长效可吸收补片修补后应从术后12至18个月开始评估复发,之后每年一次。
临床怎么用
- 可根据补片类型制定差异化的复发随访策略,长效可吸收补片可推迟首次复发评估至12至18个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long-term follow-up outcomes of ventral hernia repairs (VHRs) with meshes are unavailable. Knowledge of these meshes at distant timepoints will be useful in selecting optimal mesh for VHRs. Our study aimed to develop a highly accurate model to validate and predict long-term recurrence data of open VHRs and further determine the optimal timing of follow-up for different VHRs with different meshes. STUDY DESIGN: Using population survival kinetics, 1-phase nonlinear regression analysis was used to determine the overall time to recurrence for repairs with all 3 mesh types. Time to recurrence was used to validate and predict the year-over-year recurrence data for each specific mesh type. RESULTS: The model found the median overall time to recurrence to be longest for long-acting resorbable meshes (166.4 months), followed by synthetic meshes (132.1 months) and shortest for biologic meshes (80 months). At 5 years, about 41% of VHRs with biologic meshes, 27% with synthetic meshes, and 22% with long-acting resorbable meshes are expected to fail due to recurrence; at 10 years, these rates will rise to 65%, 47%, and 39%, respectively. Biologic meshes will have the highest proportion of "at-risk" repairs (42%). At 15 years after repair, 98% to 99% of the remaining unrecurred VHRs in the biologic and synthetic meshes will remain intact beyond that timepoint. Patients who had VHR with biologic and synthetic meshes should be evaluated for recurrence every 6 months for 2 years, then yearly for up to 15 years. Patients repaired with long-acting resorbable meshes should be evaluated for recurrence starting at 12 to 18 months after repair, then yearly. CONCLUSIONS: We demonstrate the first application of population survival kinetics in the surgery literature. Long-acting resorbable meshes have the longest time to recurrence and the lowest recurrence rates for 5 and 10 years, suggesting superior long-term performance compared with synthetic and biologic meshes.
引用
- Elemosho A, Janis JE. Comparative Long-Term Performance of Biologic, Synthetic, and Long-Acting Resorbable Meshes in Ventral Hernia Repair: Population Survival Kinetics Approach. J Am Coll Surg. 2025. PMID: 40439256. doi:10.1097/XCS.0000000000001412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。